• About us
• Contact

Advertisement

Person › Details

Bassil Dahiyat (Xencor Inc. (Nasdaq: XNCR))

Dahiyat, Bassil (Xencor 200607 President + CEO)

 

	Organisation	Xencor Inc. (Nasdaq: XNCR)
	Product	Xtend™ technology

Record changed: 2020-03-27

Advertisement

More documents for Bassil Dahiyat

• [1] Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA....
• [2] Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.